French pharmaceutical giant Sanofi announced Monday that it will acquire U.S.-based Blueprint Medicines for $9.1 billion to strengthen its portfolio in rare immunological diseases.
France-based pharmaceutical company Sanofi announced Monday that it will acquire U.S.-based Blueprint Medicines Corporation for $9.1 billion, in a strategic move to bolster its presence in rare immunological diseases.
Blueprint, a biopharmaceutical company specializing in systemic mastocytosis (SM) and other KIT-driven diseases, accepted Sanofi’s offer of $129 per share in cash. The offer represents a 27% premium over Blueprint’s last closing price of $101.35 on Friday.
The acquisition includes Ayvakit (avapritinib), a treatment for SM approved in both the U.S. and EU, along with a robust early- and late-stage immunology pipeline.
“Blueprint’s established relationships with allergists, dermatologists, and immunologists are expected to enhance Sanofi’s growing immunology portfolio,” the French company said in a statement.
The transaction is expected to close in the third quarter of 2025, pending regulatory approvals.
As part of the deal, Blueprint shareholders will also receive one non-tradeable contingent value right (CVR), entitling them to potential milestone payments of $2 and $4 per CVR based on future achievements.
Blueprint is currently the only company with an approved drug for systemic mastocytosis - a rare disorder caused by excess mast cells - and is also developing next-generation therapies for SM and other immune disorders.
The acquisition marks the largest healthcare M&A deal in Europe so far this year. It follows Sanofi’s recent purchase of Vigil Neuroscience for $470 million last month - the second time the French company has acquired Vigil in 2025, after an initial purchase in January.
Since the end of the 2020 conflict with Armenia, Azerbaijan continues to grapple with the enduring danger of landmines scattered across its regained t...
U.S. President Donald Trump has invited the leaders of Kazakhstan and Uzbekistan to attend the G20 summit set to be hosted in Miami next year....
The Iranian government has announced plans to build nuclear power plants using domestic industrial capacity in conjunction with Russia....
Uzbekistan is exploring potential cooperation with The Walt Disney Company on creative and tourism projects, including a long-term proposal to build a...
France’s government is moving to pass emergency legislation to keep the state operating into January after lawmakers failed to agree on a 2026 budge...
Since the end of the 2020 conflict with Armenia, Azerbaijan continues to grapple with the enduring danger of landmines scattered across its regained territories.
Diplomatic efforts to end the war between Russia and Ukraine remain at an early and uncertain stage, despite increased international engagement.
Start your day informed with AnewZ Morning Brief: here are the top news stories for the 24th of December, covering the latest developments you need to know.
The U.S. Supreme Court blocked Donald Trump's attempt to send National Guard troops to the Chicago area, amid concerns that the Republican president is using the military in Democratic-led regions to punish opponents and suppress dissent on Tuesday.
Vince Zampella, co-creator of the Call of Duty gaming franchise, has died in a car crash involving a Ferrari crash on Monday in Los Angeles, United States.
Israeli Prime Minister Benjamin Netanyahu said Israel is monitoring recent Iranian military exercises and will raise the issue with U.S. President Donald Trump during his visit to Washington next week.
Paramount has reaffirmed its bid to acquire Warner Bros. Discovery, offering $30 per share in cash and backing the proposal with a $40.4 billion personal equity guarantee from billionaire Larry Ellison, despite the target company’s board urging shareholders to reject the offer.
U.S. President Donald Trump has approved plans to construct a new class of battleships, which he described as larger, faster and significantly more powerful than any previous U.S. warship.
As the European Commission warns of possible visa suspension, Georgian authorities reject accusations of democratic backsliding. What is really at stake — and who could be affected most?
An international scientific-practical congress marking the 90th anniversary of the Azerbaijan State Advanced Training Institute for Doctors named after Aziz Aliyev has opened in Baku.
China has announced plans to fully cover childbirth-related costs for families as authorities move to incentivise young couples to have more children.
World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus said on Thursday that he still hopes the U.S. administration will reconsider its decision to withdraw from the organisation next month, warning that its exit would be a loss for the world.
The United States has signed significant health cooperation agreements with Uganda and Lesotho, further strengthening bilateral relations and advancing global health initiatives, the U.S. State Department announced on Wednesday.
A viral claim circulating online that Denmark requires sperm donors to have an IQ of at least 85 is misleading. While one Danish sperm bank, Donor Network, does use an IQ threshold, there is no nationwide legal requirement for donors to meet a specific level of intelligence.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment